Edgewise Therapeutics, Inc. (NASDAQ: EWTX)
$27.5100
+0.8100 ( +2.84% ) 290.7K
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
Market Data
Open
$27.5100
Previous close
$26.7000
Volume
290.7K
Market cap
$2.53B
Day range
$26.5000 - $27.9900
52 week range
$9.0000 - $38.1200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 2 | Dec 27, 2024 |
| 8-k | 8K-related | 53 | Dec 16, 2024 |
| 10-q | Quarterly Reports | 53 | Nov 07, 2024 |
| 8-k | 8K-related | 15 | Nov 07, 2024 |
| 4 | Insider transactions | 1 | Oct 16, 2024 |
| 4 | Insider transactions | 1 | Sep 24, 2024 |
| 4 | Insider transactions | 1 | Sep 24, 2024 |
| 4 | Insider transactions | 1 | Sep 24, 2024 |
| 4 | Insider transactions | 1 | Sep 24, 2024 |
| 4 | Insider transactions | 1 | Sep 24, 2024 |